COVID Nimbus, known as NB.1.8.1, is a COVID‑19 subvariant that emerged in early 2025, spreading rapidly across Asia, Europe, and the U.S. This variant evolved from earlier Omicron lineages and includes spike protein mutations that enhance ACE2 receptor binding, contributing to faster transmission in indoor and community settings. While highly contagious, current data show that NB.1.8.1 does not significantly increase hospitalizations or severe disease for most people, especially those vaccinated or previously infected.
Symptoms of COVID Nimbus generally resemble earlier Omicron strains but include a particularly sharp sore throat along with fatigue, mild cough, and congestion. Vaccination, antiviral treatments, and basic precautions like masking and ventilation remain effective in reducing both transmission and severe outcomes. Understanding these symptoms, high-risk groups, and prevention strategies is critical as the variant continues to circulate globally.
